HDFC Bank Limited Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? HDFC Bank Limited Common Stock trades at $22.28 (market cap $112.43B), while ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B). The key difference: HDFC Bank Limited Common Stock is far larger — about 10.9× ImmunityBio Inc. Common Stock's market cap, and HDFC Bank Limited Common Stock pays a 1.85% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HDFC Bank Limited Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| HDB | IBRX | |
|---|---|---|
Market Cap | $112.43B | $10.33B |
Volume | 7,511,454 | 11,745,198 |
Sector | Financials | Health |
52-Week High | $37.18 | $11.55 |
52-Week Low | $21.84 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95T | $10.79B |
Dividend Yield | 1.85% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HDFC Bank provides retail, wholesale, and treasury banking services in India. Its offerings include deposits, lending, payments, trade finance, and financial services for individuals and businesses.
Read more on HDB →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →